Description
Lanifibranor is a novel pan-PPAR (peroxisome proliferator-activated receptors) agonist.
Lanifibranor is a novel pan-PPAR (peroxisome proliferator-activated receptors) agonist.
B1996 | Lanifibranor DataSheet
Alternate Name/Synonyms: 4-(1-(1,3-Benzothiazol-6-ylsulfonyl)-5-chloro-indol-2-yl)-butan-oic acid; IVA-337
Appearance: Crystalline solid
Formulation: N/A
CAS Number: 927961-18-0
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₁₉H₁₅ClN₂O₄S₂
Molecular Weight: 434.91
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A novel pan-PPAR (peroxisome proliferator-activated receptors) agonist
MDL Number: N/A
PubChem CID: 68677842
SMILES: C1=CC2=C(C=C1S(=O)(=O)N3C4=C(C=C(C=C4)Cl)C=C3CCCC(=O)O)SC=N2
InChi: InChI=1S/C19H15ClN2O4S2/c20-13-4-7-17-12(8-13)9-14(2-1-3-19(23)24)22(17)28(25,26)15-5-6-16-18(10-15)27-11-21-16/h4-11H,1-3H2,(H,23,24)
InChi Key: OQDQIFQRNZIEEJ-UHFFFAOYSA-N
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |